O-GlcNAcase-IN-3

• Description:

  O-GlcNAcase-IN-3 (Compound I) is an OGA inhibitor. O-GlcNAcase-IN-3 can be used for Alzheimer's Disease (AD) research[1].

• UNSPSC:

  12352005

• Target:

  OGA

• Related Pathways:

  Neuronal Signaling

• Field of Research:

  Neurological Disease

• Smiles:

  COC1=NC=NC(O[C@@H]2C[C@H](C)N(CC3=C(F)N=C(NC(C)=O)S3)C2)=C1.O[C@H]([C@@H](O)C(O)=O)C(O)=O

• Molecular Formula:

  C20H26FN5O9S

• Molecular Weight:

  531.51

• References & Citations:

  [1]NERY O'DONNELL F C, et al. N-[4-fluor-5-[[ (2s, 4 r) -4-[ (6-methoxy-4-pyrimidinyl) oxy]- 2-methyl-1-pyrrolidinyl] methyl ]-2-thiazolyl]acetamid for use in the treatment of alzheimer disease. WO2025184490A1. 2025-09-04.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2760514-33-6]